1-3 of 3
Atsushi Miwa
Close
Sort by
Journal Articles

Ki11502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo

Chie Nishioka, Takayuki Ikezoe, Jing Yang, Atsushi Miwa, Taizo Tasaka, Yoshio Kuwayama, Kazuto Togitani, H. Phillip Koeffler, Akihito Yokoyama
Journal: Blood
Blood (2008) 111 (10): 5086–5092.
https://doi.org/10.1182/blood-2007-06-098079
Published: 2008
Includes: Supplemental data
Journal Articles

Single Oral Administration of KRN383, a Novel Flt3 Inhibitor, Induces Eradication of the Xenograft Tumor Harboring Flt3 Mutation in Mice.

Uichi Nishiyama, Masako Ozai, Rieko Yoshioka, Tetsuya Yoshino, Yuko Ogasawara, Miyuki Kitahori, Eiji Yoshioka, Kazuo Kubo, Yukiko Komeno, MD, Mineo Kurokawa, MD, PhD, Seishi Ogawa, MD, PhD, Shigeru Chiba, MD, PhD, Tatsushi Osawa, PhD, Tomoaki Kuwaki, Hisamaru Hirai, MD, PhD, Atsushi Miwa, PhD
Journal: Blood
Blood (2004) 104 (11): 2545.
https://doi.org/10.1182/blood.V104.11.2545.2545
Published: 2004
Journal Articles

Ki23819 (KRN383•HCl) Inhibits Kinase Activity of Wild Type and Mutant FLT3 Receptor Tyrosine Kinase In Vitro .

Yukiko Komeno, Mineo Kurokawa, Yoichi Imai, Masataka Takeshita, Tomoko Matsumura, Kazuo Kubo, Tetsuya Yoshino, Uichi Nishiyama, Tomoaki Kuwaki, Kinya Kubo, Tatsushi Osawa, Seishi Ogawa, Shigeru Chiba, Atsushi Miwa, Hisamaru Hirai
Journal: Blood
Blood (2004) 104 (11): 1168.
https://doi.org/10.1182/blood.V104.11.1168.1168
Published: 2004